Approaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition

dc.contributor.authorBonjoch Gassol, Laia
dc.contributor.authorMur, Pilar
dc.contributor.authorArnau Collell, Coral
dc.contributor.authorVargas Parra, Gardenía María
dc.contributor.authorShamloo, Bahar
dc.contributor.authorFranch Expósito, Sebastià
dc.contributor.authorPineda Riu, Marta
dc.contributor.authorCapellá, G. (Gabriel)
dc.contributor.authorErman, Batu
dc.contributor.authorCastellví Bel, Sergi
dc.date.accessioned2021-03-16T07:56:12Z
dc.date.available2021-03-16T07:56:12Z
dc.date.issued2019-10-01
dc.date.updated2021-03-16T07:56:13Z
dc.description.abstractMost next generation sequencing (NGS) studies identified candidate genetic variants predisposing to colorectal cancer (CRC) but do not tackle its functional interpretation to unequivocally recognize a new hereditary CRC gene. Besides, germline variants in already established hereditary CRC-predisposing genes or somatic variants share the same need when trying to categorize those with relevant significance. Functional genomics approaches have an important role in identifying the causal links between genetic architecture and phenotypes, in order to decipher cellular function in health and disease. Therefore, functional interpretation of identified genetic var iants by NGS platforms is now essential. Available approaches nowadays include bioinformatics, cell and mo lecular biology and animal models. Recent advances, such as the CRISPR-Cas9, ZFN and TALEN systems, have been already used as a powerful tool with this objective. However, the use of cell lines is of limited value due to the CRC heterogeneity and its close interaction with microenvironment. Access to tridimensional cultures or organoids and xenograft models that mimic the in vivo tissue architecture could revolutionize functional ana lysis. This review will focus on the application of state-of-the-art functional studies to better tackle new genes involved in germline predisposition to this neoplasm.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec706830
dc.identifier.issn0098-2997
dc.identifier.pmid30935834
dc.identifier.urihttps://hdl.handle.net/2445/175148
dc.language.isoeng
dc.publisherElsevier Ltd
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.mam.2019.03.004
dc.relation.ispartofMolecular Aspects of Medicine, 2019, vol. 69, p. 27-40
dc.relation.urihttps://doi.org/10.1016/j.mam.2019.03.004
dc.rightscc-by-nc-nd (c) Bonjoch, Laia et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCàncer colorectal
dc.subject.classificationMalalties hereditàries
dc.subject.classificationCribratge genètic
dc.subject.classificationGenòmica
dc.subject.otherColorectal cancer
dc.subject.otherGenetic diseases
dc.subject.otherGenetic screening
dc.subject.otherGenomics
dc.titleApproaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
706830.pdf
Mida:
1.42 MB
Format:
Adobe Portable Document Format